This company has registrations in United States, Brazil, Canada, Taiwan, South Korea, Australia, Israel, Russia — 8 overseas markets. The China NMPA lookup is still pending.
Company-name search in every official database is a substring match and returns same-named but different companies. Each figure below is the count after re-checking every record against the manufacturer name.
Fields marked "pending" have not been obtained yet; that does not mean they do not exist. Risk records (litigation, penalties, operating anomalies) are kept internal and not published.
| Market | Identifier | Name | Class / date |
|---|---|---|---|
| US | K172745 | ImmuGlo HEp-2 Elite IFA | 2018-06-05 |
| US | K172078 | ImmuLisa Enhanced RNA POL III Antibody ELISA | 2018-03-30 |
| US | K163133 | ImmuLisa Enhanced AMA IgG Antibody ELISA; ImmuLisa Enhanced AMA IgA/IgG/IgM Antibody ELISA | 2017-08-08 |
| BR | 80944340028 | ImmuGlo HEp-2 Elite IFA | Class II |
| BR | 80944340029 | ImmuLisa Celiac G+ IgG | Class II |
| BR | 80944340030 | ImmuGlo HEp-2 Cells Anti Nuclear Antibody IFA Kit | Class II |
| CA | 85241 | IMMULISA PR3 ANTIBODY ELISA | Class II |
| CA | 85243 | IMMULISA ENHANCED ACA ELISAS (IGG) | Class II |
| CA | 85334 | IMMULISA MPO ANTIBODY ELISA | Class II |